Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis

W Tong, H Xu, J Tang, N Zhao, D Zhou, C Chen… - Scientific Reports, 2024 - nature.com
This study aimed to explore the association between inflammation-based prognostic
markers and outcomes in non-small cell lung cancer (NSCLC) patients undergoing therapy …

Development of graphene oxide-based nano-delivery system for natural chemotherapeutic agent (Caffeic Acid)

S Tiwari, AD Sontakke, K Baruah, MK Purkait - Materials Today …, 2023 - Elsevier
In this work, a graphene oxide-based nano-delivery system was designed for a sustainable
release of caffeic acid. The graphene oxide (GO) nanocarrier was prepared by employing …

[HTML][HTML] The efficacy of neoadjuvant immune checkpoint inhibitors in lung squamous cell carcinoma and adenocarcinoma: a systematic review and single-arm meta …

J Dong, Q Wang, R Wang, K Ye, Z Ye… - Journal of Thoracic …, 2024 - pmc.ncbi.nlm.nih.gov
Background Neoadjuvant immunotherapy is effective in treating resectable non-small cell
lung cancer (NSCLC) but shows different responses in lung squamous cell carcinoma …

Anti-Angiogenic Agents Combined with Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

H Lin, C Ma, A Zhong, H Zang, W Chen… - … Chemistry & High …, 2024 - ingentaconnect.com
Background: Anti-angiogenic agents could enhance tumor immunity response, and anti-
angiogenesis plus immunotherapy has become a novel treatment option for advanced non …

Integrated serum pharmacochemistry, network pharmacology and experimental verification to explore the mechanism of Aconiti Lateralis Radix Praeparata in …

W Zhang, S Cai, W Luan, M Ding, L Di - Journal of Pharmaceutical and …, 2025 - Elsevier
Abstract Aconiti Lateralis Radix Praeparata (Fuzi) is a traditional Chinese medicine (TCM)
widely used in treating cancer. Our formerly investigations confirmed the anti-lung cancer …

[PDF][PDF] PEG-rhG-CSF 预防小细胞肺癌化疗后中性粒细胞减少症的效果分析

刘社清 - 中国医学创新 - zgyxcx.com
目的: 探讨聚乙二醇化重组人粒细胞刺激因子(PEG-rhG-CSF) 预防小细胞肺癌化疗后中性粒
细胞减少症的效果. 方法: 选取2020 年1 月—2023 年3 月北京市朝阳区桓兴肿瘤医院收治的小 …